Brief: Zivo Bioscience executes debt restructuring
06/03/2017 22:00
March 7 (Reuters) - Zivo Bioscience Inc ZIVO.PK
* Zivo Bioscience, Inc. Executes debt restructuring with
private equity firm Hep Investments, Llc
* Zivo Bioscience, Inc. Executes debt restructuring with
private equity firm HEP Investments, Llc
* Zivo Bioscience Inc - restructured agreement extends
maturity date to september 30, 2018
* Zivo Bioscience Inc - company has successfully negotiated
and executed a restructured agreement with private equity firm
Hep Investments, Llc
* Zivo Bioscience Inc - "restructuring removes nearly $8
million from short-term liabilities and positively affects
balance sheet"
* Zivo Bioscience - existing financing instrument remains
capped at $17.5 million, leaving co with ability to access
additional $4.5 million in short-term funding
Source text for Eikon: ID:nGNXNQOWNa
Further company coverage: ZIVO.PK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Zivo Bioscience
See all newsBrief: Zivo Bioscience Plans New Study With University Of Delaware To Combat Avian Influenza In Poultry
Brief: Zivo Bioscience Reports Preliminary Efficacy Of Its Proprietary Active Ingredients In Battle Against Avian Influenza
Brief: Zivo Bioscience Initiates 42-Day Validation Study With Immune-Modulating Product
Brief: Zivo Bioscience Announces Reverse Stock Split
Brief: Trial Results Confirm Efficacy Of Zivo Bioscience’S Non-Antibiotic Product Candidate For The Prevention And Treatment Of Coccidiosis In Broiler Chickens